"Stepped back, took a look, saw a pimple on an elephants arse....just saying."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dana Develops Industry-First Battery Cooling Technology for Electric Vehicleshttp://ih.advfn.com/p.php?pid=nmona&article=40316188&symbol=NYSE:DAN&cb=1257961850
BioElectronics Announces Financial Audithttp://ih.advfn.com/p.php?pid=nmona&cb=1257958892&article=39974357&symbol=NO%5EBIEL
All in the longs favor:
FDA May Restrict Acetaminophenhttp://www.webmd.com/pain-management/news/20090701/fda-may-restrict-acetaminophen
Acetaminophen May Be Linked to Asthma Riskhttp://www.webmd.com/asthma/news/20091105/acetaminophen-may-be-linked-to-asthma-risk
Acetaminophen (Tylenol) Poisoning Overviewhttp://www.emedicinehealth.com/acetaminophen_tylenol_poisoning/article_em.htm
And look what BIEL did today, NPHC time is coming soon.
http://ih.advfn.com/p.php?pid=nmona&article=40315297&symbol=USOTC:BIEL&cb=1257958069The fact that a U.S. Food and Drug Administration advisory panel and federal regulators have taken aim at over-the-counter (OTC) acetaminophen products is not just the stuff of recent headlines. In fact, since as far back as 1977, FDA advisers have recommended explicit warnings not to exceed the dose or take acetaminophen for more than 10 days "because severe liver damage may occur." Back then, the FDA never followed that advice although they pledged to quickly consider its advisers' recommendations.
Speculators Betting on BioElectronics' Upcoming Study Resultshttp://ih.advfn.com/p.php?pid=nmona&article=40315297&symbol=USOTC:BIEL&cb=1257958069
.08 gone.
MCLM got a lot more @ .006.
Did they not just announce recently that they have enough cash for current needs? Anyway the positive side is that they might require more cash to fry some bigger fish in the not to distant future.
Well, you know about gaps and there is one sitting there.
Solos Endoscopy, Inc.'s Breast Endoscopy System Featured in November Issue of Healthcare Purchasing News Magazinehttp://ih.advfn.com/p.php?pid=nmona&article=40311329&symbol=USOTC:SNDY&cb=1257946377
Even though it was a fairly quiet volume day it was more volatile than I have seen it in a while. Sudden spikes, sudden drops.
They will be back, always are. No time to be complacent.
My monitors are hardly blinking. Finding it hard to stay awake. zzzzzzzzzzzz
Was wondering why it was only filed today.
NPHC Statement of Changes in Beneficial Ownership (4) http://investorshub.advfn.com/boards/read_msg.aspx?message_id=43424956
Statement of Changes in Beneficial Ownership (4)
http://ih.advfn.com/p.php?pid=nmona&article=40297521&symbol=USBB:NPHC&cb=1257877074
I was referencing to the volume mate. And no I was using todays information.
Yes folks they actually have it down between 5-10% with the buys outnumbering the sells. Someone is getting desperate!
6.8k buys vs 6.3k sells. Obviously no one was induced into a panic selloff with the MM taking it down 10% on pathetic volume. This is a good sign for now, everyone is just holding on. Just the games they like to play. This is winding up tighter and tighter. Any day now.
Any news on this spike? Cannot find any.
Shaking the tree on very low volume this is where you add some. Something has to give.
.01x.011 time to move this puppy.
550k spending on advertising that should give us all some indication on current and expected sales. This is very good news. You do not spend that kind of money if you are not aware of what your sales potential is. Nice!
MCLN, I like the positive cash flow and transparency. I like what I see.
Patience mate. It will all come together.
Why not? Surely the lab facility should be completed by now and FDA approved or at lease very close.
Nice move!
If you see the potential in this stock you might as well load up with some XCHO as well.
Yes, a good old squeeze going on there today. Same will happen here soon.
Welcome mate!
The squeeze is on.
Technical Analysis Video Presentation of NPHC http://investorshub.advfn.com/boards/read_msg.aspx?message_id=43363287
D.C. Vaccine Conference Attracts Government Policy Makers and Biotech Innovators
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, reports that On Monday and Tuesday of this week, the 7th Annual Vaccines: All Things Considered Conference is taking place in Washington, DC. Investors should keep an eye on this event, which serves as a one-stop destination for valuable updates and exposure on all aspects of vaccine research, development, regulations, and policy via key, intimate presentations by innovative biotech companies and government regulators.
Organizers aim to provide exposure to all avenues of vaccine research, development, regulations and policy and updates on the flu pandemic, bio-defense policy. The National Vaccine Plan will also be addressed and discussed.
Several government officials, including representatives from the United States Department of Health and Human Services, National Research Council of Canada, National Institutes of Health, National Institute of Allergy and Infectious Disease, and the Food and Drug Administration, come together at this conference with representatives from several key biotech and pharmaceutical companies.
"The research and discovery of vaccines to fight globally prevalent diseases has been a major focus of the pharmaceutical industry’s biggest players for decades," say members of the conference's organizing committee. "The pharmaceutical world has recently been rocked by the pending expiration of patents on several major block-buster drugs. How does this affect funding for vaccine research and development? What will be the path forward? How will the generic drug industry affect the vaccines market? These are just a few of the questions the Vaccines conference will address and answer."
Scheduled to present the event's opening remarks and to moderate several of the key presentation sessions is Dr.Daniel Zimmerman, Ph.D., Senior Vice President Research and Development, Cellular Immunology for CEL-SCI Corporation (AMEX:CVM). Zimmerman's work at the company in partnership with several research university partners has been attracting a great deal of attention in both the H1N1 influenza and inflammatory disease space lately.
Companies who will share the spotlight in front of some of the key officials from the government agencies include:
Ibis Biosciences, Inc., Immunovaccine, Inc.(CVE:IMV), Advaxis, Inc.(OTC:ADXS) , EpiVax, VaxArt, VaxDesign, and at least three big pharmaceutical companies including Novartis (NYSE:NVS), Sanofi Pasteur, and Merck (NYSE:MRK).
Representatives from the academic research field will include:
Dr. Kenneth S. Rosenthal, Ph.D., ProfessorMicrobiology/Immunology, Northeastern Ohio Universities Colleges of Medicine and Pharmacy
Pirouz DaftarianHead, Biological Modifiers Laboratory, University of Miami
The complete report is available now at BioMedReports.Com:
http://biomedreports.com/articles/most-popular/17010-dc-vaccine-conference-attracts-government-policy-makers-and-key-biotech-innovators.html
Biotech investors interested in accessing the news portal's complete database of clinical trials and upcoming FDA decisions can access that information here:
http://biomedreports.com/fda-calendar/fda-calendar.html
About BioMedReports.Com
BioMedReports.Com is a news portal covering the biomedical news and financial sector. BioMedReports is not paid, compensated or in any way incentivized to report news and developments about publicly traded companies.
For more biomedical sector and investment news go to http://BioMedReports.com
Never checked on Sprint price before, was just browsing. I use Sprint service for at least five years now, service has become better over the years.
Wow, this was almost a $25 stock two and a half years ago and been in a down ward trend ever since. Well I guess not as bad as Revlon (REV) that put in a 13 year low at about $2.40 and now trading at $10.
I think that S has to go test that low down there at about $1.30. There is nothing much to indicate that the trend is not going to continue downward.
Have put it on my watch list. IMO
Maybe I am just seeing things but two Fridays in a row now, this sick puppy gets held down all day long then right at the close they let it run back up. Every morning also it runs up to the high of the day and then it is down all the way for the rest of the day.
I know you are here for the long haul and sorry if I am boring you but there is some manipulation going on here. I have watched it long enough now, to pick up the patterns. But then again which stock is not manipulated in some form or manner?
Have a great weekend.
I was compelled to add some more today. Hope you all have a great weekend. (pain free)
Put some sherbet powder on the tip of your finger.
Drawing the handle on the cup. One day chart. Next leg should be up.